Health knowledge made personal
Join this community!
› Share page:
Search posts:

IF in or Around London, HL621 – Get £60 for taking part in an interview about Multiple Sclerosis

Posted Mar 07 2011 12:00am

Thanks for your interested in our latest research project about MS.  We are carrying out a market research survey among people with multiple sclerosis to understand the treatment choices MS patients are provided with and factors that influence which treatment you receive.
The research will take the form of a 60 minute interview and will take place face to face.  You can either come to central London to be interviewed or we can send an interviewer to your own home so you do not need to travel. 
If you do take part in the interview we will reward you with £60 to thank you for your time and effort.
In this case not all Multiple sclerosis patients will qualify.  You  will need to meet at least the following criteria:-
·         1. Have been diagnosed with multiple sclerosis·         2. Have or are  being treated with one of the following•   Avonex  / beta interferon 1a•   Betaferon/ Extavia /beta interferon 1b•   Copaxone  / glatiramer acetate•   Rebif /beta interferon 1a·         3. Be available for an interview between 8th March 2011 and 24th March 2011·         4. Based in or around London.
If you wish to take part please write to me at  giving a telephone number where we can contact you.  Please could you put either HL621 London MS  in the subject line for easy reference?
If you know somebody who may be interested please get in touch.
One of my colleagues will give you a call to discuss the research in more detail and to set up a time for your interview.

=================== ****************************************************************
"Providing You with 'MS Views and News', is what we do"
Remain CURRENT with educational information of
 Multiple Sclerosis when registered at
the  MS Views and News   website.
  Please donate   - all contributions are tax deductible - *************************************************************************************** Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services  ****************************************************************
Post a comment
Write a comment:

Related Searches